Browse > Article

Effect of Water Extract of Cynanchi Wilfordii Radix in RANKL-induced Osteoclast Differentiation  

Ahn, Yong-Hwan (Department of Anatomy, Institute for Skeletal Disease & Institute for Environmental Science, Wonkwang Medical Science, College of Medicine)
Oh, Jae-Min (Department of Anatomy, Institute for Skeletal Disease & Institute for Environmental Science, Wonkwang Medical Science, College of Medicine)
Lee, Myeung-Su (Department of Internal Medicine, Division of Rheumatology & Institute of Wonkwang Medical Science, College of Medicine)
Jung, Jong-Hyuk (Department of Internal Medicine, Division of Rheumatology & Institute of Wonkwang Medical Science, College of Medicine)
Chae, Soo-Uk (Department of Orthopedic Surgery, Gunsan Medical Center)
Moon, Seo-Young (Division of Anesthesiology and Pain Medicine, Sanbon Medical Center)
Jeon, Byung-Hoon (Department of Pathology & Research Center of Traditional Korean Medicine, College of Oriental Medicine, Wonkwang University)
Choi, Min-Kyu (Department of Anatomy, Institute for Skeletal Disease & Institute for Environmental Science, Wonkwang Medical Science, College of Medicine)
Publication Information
Journal of Physiology & Pathology in Korean Medicine / v.26, no.2, 2012 , pp. 160-165 More about this Journal
Abstract
Osteoporotic fracture became a serious social problem, which related with mortality and morbidity in old age population. Osteoclast which is responsible for bone resorption is originated from hematopoietic cell line and plays a key role osteoporotic bone loss. Cynanchum wilfordii (Asclepiadaceae) roots have been used in Korean folk medicine for the treatment of diabetes mellitus and aging progression. Also, recent studies have shown that the extract and fractions of Cynanchi Wilfordii Radix have various pharmacological actions including scavenging free radicals, enhancing immunity, reducing high serum cholesterol, and anti-tumor activity. However, the effect of extract of Cynanchi Wilfordii Radix in osteoclast differentiation had not been reported. Thus, we evaluated the effect of Cynanchi Wilfordii Radix on receptor activator of nuclear factor-${\kappa}B$ ligand (RANKL)-induced osteoclast differentiation. Through our study, we found that Cynanchi Wilfordii Radix significantly inhibited osteoclast differentiation induced by RANKL. Cynanchi Wilfordii Radix suppressed the activation of p38 pathway and $NF{\kappa}B$ in bone marrow macrophages (BMMs) treated with RANKL. Also, Cynanchi Wilfordii Radix significantly inhibited the mRNA expression of c-Fos, tartrate-resistant acid phosphatase (TRAP), osteoclast-associated receptor (OSCAR), nuclear factor of activated T cells (NFAT)c1 and cathepsin K in BMMs treated with RANKL. Particularly, Cynanchi Wilfordii Radix inhibited the protein expression of c-fos and NFATc1. Taken together, our results demonstrated that Cynanchi Wilfordii Radix may be useful treatment option of bone-related disease such as osteoporosis leads to fracture of bone and rheumatoid arthritis.
Keywords
Cynanchi Wilfordii Radix; Osteoporosis; Osteoclast; RANKL;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J., Wagner, E.F., Mak, T.W., Kodama, T., Taniguchi, T. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Developmental Cell 3: 889-901, 2002.   DOI   ScienceOn
2 Galibert, L., Tometsko, M.E., Anderson, D.M., Cosman, D., Dougall, W.C. The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-${\kappa}B$, a member of the TNFR superfamily. J Biol Chem 273: 34120-34127, 1998.   DOI   ScienceOn
3 Shimizu, H., Nakagami, H., Tsukamoto, I., Morita, S., Kunugiza, Y., Tomita, T., Yoshikawa, H., Kaneda, Y., Ogihara, T., Morishita, R. NFkappaB decoy oligodeoxynucleotides ameliorates osteoporosis through inhibition of activation and differentiation of osteoclasts. Gene Ther. Jun; 13(12):933-941, 2006.   DOI   ScienceOn
4 Cummings, S.R., Browner, W.S., Bauer, D., Stone, K., Ensrud, K., Jamal, S., Ettinger, B: Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group. N Engl J Med 339: 733-738, 1998.   DOI   ScienceOn
5 Looker, A., Johnston, C., Wahner, H., Dunn, W., Calvo, M., Harris, T., Heyse, S., Lindsay, R.J. Prevalence of low femoral bone density in older U.S. women from NHANES III. Bone Miner. Res. 10: 796-802, 1995.
6 Park, C., Ha, Y.C., Jang, S., Jang, S., Yoon, H.K., Lee, Y.K. The incidence and residual lifetime risk of osteoporosis-related fractures in Korea. J Bone Miner Metab. Nov 29(6):744-751, 2011.   DOI   ScienceOn
7 Nishikawa, M., Akatsu, T., Katayama, Y., Yasutomo, Y., Kado, S., Kugal, N., Yamamoto, M., Nagata, N. Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures. Bone 18: 9-14, 1996.   DOI   ScienceOn
8 Khosla, S., Burr, D., Cauley, J., et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 22: 1479-1491, 2007   DOI   ScienceOn
9 Park-Wyllie, L.Y., Mamdan,i M.M., Juurlink, D.N., Hawker, G.A., Gunraj, N., Austin, P.C., Whelan, D.B., Weiler, P.J., Laupacis, A. Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women. JAMA. Feb 23; 305(8):783-789, 2011.   DOI   ScienceOn
10 정연태, 최윤홍, 송정훈, 이창훈, 오재민: 두충의 물 추출물이 파골세포의 분화에 미치는 영향. 동의생리병리학회지 23(3):613-618, 2009.
11 오재민, 이명수, 김정중, 이정휴, 채수욱, 김하영, 전병훈, 박기인, 문서영, 조해중: 파골세포 분화에 미치는 복분자 물 추출물의 효과. 동의생리병리학회지 25(4):669-674, 2011.
12 한기선, 신길조, 이원철, 이종형. 白何首烏항산화활성과 amino acid의 분포에 관한 실험적 연구. 대한 한방 내과학회지 19(2):411-430, 1998.
13 Shan, L., Liu, R.H., Shen, Y.H., Zhang, W.D., Zhang, C., Wu, D.Z., Min, L., Su, J., Xu, X.K. Gastroprotective effect of a traditional Chinese herbal drug "Baishouwu" on experimental gastric lesions in rats. J. Ethnopharmacol. 107: 389-394, 2006.   DOI   ScienceOn
14 Kim, M.S., Baek, J.H., Park, J.A., Hwang, B.Y., Kim, S.E., Lee, J.J., Kim, K.W. Wilfoside K1N isolated from Cynanchum wilfordii inhibits angiogenesis and tumor cell invasion. Int J Oncol. Jun;26(6):1533-1539, 2005.
15 Korczowska, I., Olewicz-Gawlik, A. Does low-dose and short-term glucocorticoids treatment increase the risk of osteoporosis in rheumatoid arthritis female patients? Clin Rheumatol. May;27(5):565-572, 2008.   DOI   ScienceOn
16 유주열. 동의사상의학강좌. 서울, 대성문화사, p 414, 1999.
17 Jiang, Y., Choi, H.G., Li, Y., Park, Y.M., Lee, J.H., Kim, D.H., Lee, J.H., Son, J.K., Na, M., Lee, S.H. Chemical constituents of Cynanchum wilfordii and the chemotaxonomy of two species of the family Asclepiadacease, C. wilfordii and C. auriculatum. Arch Pharm Res. Dec;34(12):2021-2027, 2011.   DOI   ScienceOn
18 Lee, M.K., Yeo, H., Kim, J., Kim, Y.C. Protection of rat hepatocytes exposed to CCl4 in-vitro by cynandione A, a biacetophenone from Cynanchum wilfordii. J Pharm Pharmacol. Mar;52(3):341-345, 2000.   DOI   ScienceOn
19 Lee, M.K., Yeo, H., Kim, J., Markelonis, G.J., Oh, T.H., Kim, Y.C. Cynandione A from Cynanchum wilfordii protects cultured cortical neurons from toxicity induced by H2O2, L-glutamate, and kainate. J Neurosci Res. Jan 15;59(2):259-264, 2000.   DOI   ScienceOn
20 Dougall, W.C., Glaccum, M., Charrier, K., Rohrbach, K., Brasel, K., De medt, T., Daro, E., Smith, J., Tometsko, M.E., Maliszewski, C.R., Armstrong, A., Shen, V., Bain, S., Cosman, D., Anderson, D., Morrissey, P.J., Peschon, J.J., Schuh, J. RANK is essential for osteoclast and lymph node development. Genes & Development 13: 2412-2424, 1999.   DOI   ScienceOn